Home / Inspections / 1258246

FDA Inspection 1258246 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 1000161089

The FDA completed an inspection of Mary Bird Perkins Cancer Center on December 17, 2024 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 17, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Baton Rouge, LA (United States)

Facility

Other inspections at this facility

  • 1094459 (NAI Thu Jun 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 994363 (NAI Fri Dec 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 921199 (NAI Thu Apr 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 833712 (NAI Wed May 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 736189 (NAI Fri Jul 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources